摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

hydroxy{[4-({4-[(2-methyl-4-quinolinyl)methyl]phenyl}sulfonyl)tetrahydro-2H-pyran-4-yl]methyl}formamide | 1026390-79-3

中文名称
——
中文别名
——
英文名称
hydroxy{[4-({4-[(2-methyl-4-quinolinyl)methyl]phenyl}sulfonyl)tetrahydro-2H-pyran-4-yl]methyl}formamide
英文别名
[4-[4-[(2-Methylquinolin-4-yl)methyl]phenyl]sulfonyloxan-4-yl]methylcarbamic acid
hydroxy{[4-({4-[(2-methyl-4-quinolinyl)methyl]phenyl}sulfonyl)tetrahydro-2H-pyran-4-yl]methyl}formamide化学式
CAS
1026390-79-3
化学式
C24H26N2O5S
mdl
——
分子量
454.547
InChiKey
ORQFYKNVUFPPTR-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.4
  • 重原子数:
    32
  • 可旋转键数:
    6
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.33
  • 拓扑面积:
    114
  • 氢给体数:
    2
  • 氢受体数:
    6

文献信息

  • Beta-sulfone derivatives as inhibitors of matrix metalloproteinases and/or TNF-alpha converting enzyme (TACE)
    申请人:——
    公开号:US20030212056A1
    公开(公告)日:2003-11-13
    The present application describes novel &bgr;-sulfone derivatives of formula I: 1 or pharmaceutically acceptable salt or prodrug forms thereof, wherein R 1 , R 2 , R 3 , R 4 , R 5 , X, Y, Z, and Z a are defined in the present specification, which are useful as inhibitors of matrix metalloproteinases (MMP), TNF-&agr; converting enzyme (TACE), aggrecanase, or a combination thereof.
    本申请描述了新颖的β-砜衍生物化学式为I:1或其药用可接受的盐或前药形式,其中R1、R2、R3、R4、R5、X、Y、Z和Za在本说明中有定义,这些衍生物可用作基质蛋白酶(MMP)、TNF-α转化酶(TACE)、聚集素酶的抑制剂,或其组合。
  • [EN] beta -SULFONE DERIVATIVES AS INHIBITORS OF MATRIX METALLOPROTEINASES AND/OR TNF- alpha CONVERTING ENZYME (TACE)<br/>[FR] DERIVES DOLLAR G(B)-SULFONE UTILISES COMME INHIBITEURS DE METALLOPROTEINASES MATRICIELLES ET/OU ENZYME DE CONVERSION DE TNF- DOLLAR G(A) (TACE)
    申请人:BRISTOL MYERS SQUIBB CO
    公开号:WO2003040103A1
    公开(公告)日:2003-05-15
    The present application describes novel β-sulfone derivatives of formula (I), or pharmaceutically acceptable salt or prodrug forms thereof, wherein R?1, R2, R3, R4, R5¿, X, Y, Z, and Za are defined in the present specification, which are useful as inhibitors of matrix metalloproteinases (MMP), TNF-α converting enzyme (TACE), aggrecanase, or a combination thereof.
查看更多